|
Volumn 24, Issue 11, 2007, Pages 565-566
|
Iron overcharge in myelodysplasic syndromes and iron chelation therapy;Sobrecarga de hierro en síndromes mielodisplásicos y terapia quelante de hierro
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DEFEROXAMINE;
FERRITIN;
IRON CHELATING AGENT;
ACCURACY;
CLINICAL FEATURE;
CLINICAL PRACTICE;
COMORBIDITY;
CYTOLOGY;
DISEASE DURATION;
DRUG TOLERANCE;
HUMAN;
IRON OVERLOAD;
LETTER;
MORTALITY;
MYELODYSPLASTIC SYNDROME;
AGED;
AGED, 80 AND OVER;
CHELATION THERAPY;
FEMALE;
HUMANS;
IRON;
IRON OVERLOAD;
MALE;
MIDDLE AGED;
MYELODYSPLASTIC SYNDROMES;
|
EID: 39849105107
PISSN: 02127199
EISSN: 02127199
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (1)
|
References (5)
|